It is expected that MSD Korea will in principle ban one-on-one product presentations for individual doctors from May. Business restrictions are much stronger than the industry's 'fair competition rules'.

According to the pharmaceutical industry on the 7th, MSD Korea announced plans to improve CP to its employees on the 5th. From May, it will prohibit one-on-one product presentations between doctors and sales staff.

This is a measure according to the global headquarters' criticism that the cost used for one-on-one product presentations is excessive and the cost-effectiveness is low.


MSD Korea emphasized that one-on-one product presentations are not allowed in principle,